Webdisclosure.com

BIOPHYTIS (EPA:ALBPS)

30/03/2023 23:00

Biophytis: The Combined General Meeting will be held on second call on April 17, 2023

Voir tous les communiqués de Biophytis

BIOPHYTIS (EPA:ALBPS)

27/03/2023 08:00

Biophytis: Biophytis presented Sarconeos (BIO101) as a possible treatment candidate for long COVID after hospitalization during the 13th annual International Conference on Frailty and Sarcopenia Resea

Voir tous les communiqués de Biophytis

BIOPHYTIS (EPA:ALBPS)

17/03/2023 08:00

Biophytis announces ratio change under its American Depositary Receipt (“ADR”) program

Voir tous les communiqués de Biophytis

BIOPHYTIS (EPA:ALBPS)

09/03/2023 08:00

Biophytis To Present Positive Results of Phase 2-3 COVA Study At ERS 2023 21st Lung Science Conference

Voir tous les communiqués de Biophytis

BIOPHYTIS (EPA:ALBPS)

02/03/2023 00:00

Biophytis announces the signature of a master service agreement with Intsel Chimos, a pharmaceutical company that will operate Sarconeos (BIO101) in France for the treatment of severe forms of COVID-1

Voir tous les communiqués de Biophytis

BIOPHYTIS (EPA:ALBPS)

27/02/2023 08:00

Biophytis initiates the regulatory process for an early access authorization in France from the French National Authority for Health (HAS) for the treatment with Sarconeos (BIO101) of severe forms of

Voir tous les communiqués de Biophytis

BIOPHYTIS (EPA:ALBPS)

23/02/2023 08:00

: Biophytis To Host A Combined General Shareholder’s Meeting On March 30, 2023

Voir tous les communiqués de Biophytis

BIOPHYTIS (EPA:ALBPS)

02/02/2023 08:00

Biophytis announces positive final results of the phase 2-3 COVA study with Sarconeos (BIO101) in severe COVID-19

Voir tous les communiqués de Biophytis

BIOPHYTIS (EPA:ALBPS)

31/01/2023 08:00

Biophytis publishes its financial results for the first half of 2022

Voir tous les communiqués de Biophytis

BIOPHYTIS (EPA:ALBPS)

19/01/2023 00:00

Biophytis: Judgment of the Paris Court of Appeal of 17 January 2023 in the case between Biophytis and Negma Group Ltd

Voir tous les communiqués de Biophytis

1
2
3
4
5
6
7
8
9
10